Calpain-1 contributes to IgE-mediated mast cell activation

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Mast cells are central to allergic reactions, releasing mediators controlled by complex signaling pathways.
• Understanding mast cell signaling is key to managing allergic inflammation, but pathways remain incompletely defined.

Purpose of the Study:

• To investigate the role of calpain in immunoglobulin E (IgE)-dependent mast cell activation.
• To determine if calpain inhibition can modulate mast cell mediator secretion and allergic responses.

Main Methods:

• Examined calpain activity in IgE-activated mouse bone marrow-derived mast cells.
• Utilized calpain inhibitors and calpain-1 null mast cells for in vitro and in vivo studies.
• Analyzed downstream signaling pathways including NF-κB, IKK-SNAP23, calcium flux, MAPK, Akt, and NFAT.

Main Results:

• IgE-mediated mast cell activation enhanced calpain activity.
• Calpain inhibition reduced mast cell degranulation, TNF and IL-6 production, and late-phase allergic responses.
• Calpain-1 null mast cells exhibited attenuated degranulation, reduced cytokine/chemokine production, and impaired allergic responses.
• Calpain-1 deficiency specifically impacted the IκB-NF-κB and IKK-SNAP23 pathways, leaving others unaffected.

Conclusions:

• Calpain-1 is identified as a novel regulator of IgE-mediated mast cell activation.
• Calpain-1 plays a significant role in allergic inflammation by modulating key signaling pathways.
• Calpain-1 represents a potential therapeutic target for allergic diseases.